Business Context and Reporting Period
This Form 8-K filing by Aspen Aerogels, Inc. (Delaware) reports on events occurring on December 11, 2015, with a report date of December 11, 2015. The filing details the execution of amended and restated executive agreements effective January 1, 2016, and the granting of significant equity awards to the Chief Executive Officer.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation arrangements.
- CEO Base Salary: $480,000 annually.
- CEO Performance Bonus Target: 90% of annual base salary.
- CFO Base Salary: $283,371 annually.
- CFO Performance Bonus Target: 50% of annual base salary.
- SVP Sales & Marketing Base Salary: $300,500 annually.
- SVP Sales & Marketing Performance Bonus Target: 50% of annual base salary.
Material Changes
The primary material change is the restructuring of executive compensation effective January 1, 2016, for a three-year term. Additionally, on December 11, 2015, the Board granted new equity awards to CEO Donald R. Young under the 2014 Employee, Director and Consultant Equity Incentive Plan.
Guidance, Outlook, and Management Commentary
The filing outlines specific severance and acceleration provisions triggered by termination without cause, for good reason, or in connection with a change of control.
- CEO Severance: 2x annual base salary plus pro-rated bonus upon termination without cause/good reason. In a change of control scenario within 24 months, the bonus accelerates to 2x the target.
- Other Executives Severance: 1x annual base salary plus pro-rated bonus upon termination without cause/good reason. In a change of control scenario within 24 months, this increases to 1.5x base salary and 1.5x bonus target.
- Equity Grants to CEO:
- 78,125 restricted shares vesting based on a 2020 performance target.
- 84,745 time-based stock options (exercise price $6.40) vesting in full on the third anniversary.
- 370,181 performance-based stock options (exercise price $6.40) vesting over three to five years contingent on the stock price achieving specific 30-day VWAP hurdles ($7.68, $8.32, and $8.96).
Investor Verification Checklist
- Verify the total potential cash payout for the CEO under change of control scenarios (2x salary + 2x bonus target).
- Confirm the current stock price relative to the performance hurdles ($7.68, $8.32, $8.96) required for the CEO's performance options to vest.
- Review the full text of the executive agreements (Exhibit 1 and 2) for specific definitions of "cause" and "good reason."
- Assess the dilution impact of the 454,925 total shares/options granted to the CEO.